A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Pirbuterol
Octopamine
The risk or severity of hypertension can be increased when Mirabegron is combined with Octopamine.
Pirbuterol
Mephedrone
The risk or severity of hypertension can be increased when Mirabegron is combined with Mephedrone.
Pirbuterol
Tramazoline
The risk or severity of hypertension can be increased when Mirabegron is combined with Tramazoline.
Pirbuterol
Theodrenaline
The risk or severity of hypertension can be increased when Mirabegron is combined with Theodrenaline.
Pirbuterol
Reproterol
The risk or severity of hypertension can be increased when Mirabegron is combined with Reproterol.
Pirbuterol
Higenamine
The risk or severity of hypertension can be increased when Mirabegron is combined with Higenamine.
Pirbuterol
Ebselen
The risk or severity of hypertension can be increased when Mirabegron is combined with Ebselen.
Pirbuterol
Idazoxan
The risk or severity of hypertension can be increased when Mirabegron is combined with Idazoxan.
Pirbuterol
Piclozotan
The risk or severity of hypertension can be increased when Mirabegron is combined with Piclozotan.
Pirbuterol
Dopexamine
The risk or severity of hypertension can be increased when Mirabegron is combined with Dopexamine.
Pirbuterol
Tulobuterol
The risk or severity of hypertension can be increased when Mirabegron is combined with Tulobuterol.
Pirbuterol
Abediterol
The risk or severity of hypertension can be increased when Mirabegron is combined with Abediterol.
Pirbuterol
Ritobegron
The risk or severity of hypertension can be increased when Mirabegron is combined with Ritobegron.
Pirbuterol
PF-00610355
The risk or severity of hypertension can be increased when Mirabegron is combined with PF-00610355.
Pirbuterol
Tetrahydrocannabivarin
The risk or severity of hypertension can be increased when Mirabegron is combined with Tetrahydrocannabivarin.
Pirbuterol
Rilmenidine
The risk or severity of hypertension can be increased when Mirabegron is combined with Rilmenidine.
Pirbuterol
Detomidine
The risk or severity of hypertension can be increased when Mirabegron is combined with Detomidine.
Pirbuterol
Romifidine
The risk or severity of hypertension can be increased when Mirabegron is combined with Romifidine.
Pirbuterol
Ractopamine
The risk or severity of hypertension can be increased when Mirabegron is combined with Ractopamine.
Pirbuterol
Atipamezole
The risk or severity of hypertension can be increased when Mirabegron is combined with Atipamezole.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3